Interesting facts
Exciting Facts about 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethyl-pyrimidine-2,4-dione
This compound is a fascinating example of a synthetic organic molecule with potential biological significance. Here are a few highlights that showcase its importance:
- Pharmacological Potential: Compounds like this one often belong to a class of drugs known as antidepressants or anxiolytics, indicating they may interact with neurotransmitter systems in the brain.
- Structural Complexity: The molecule is rich in functional groups, making it a great example of how different moieties can be combined to achieve specific biological effects. Its structural design includes a piperazine ring, which is common in pharmaceutical chemistry.
- Synthetic Routes: The synthesis of such compounds often involves multi-step reactions that can be quite intricate, emphasizing the skillful manipulation of organic reactions in the lab.
- Research Applications: This compound is likely to attract attention in the field of medicinal chemistry and pharmacology, where researchers are keen to discover new lead compounds for drug development.
In conclusion, 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethyl-pyrimidine-2,4-dione represents a promising chemical entity with intriguing possibilities in therapeutic applications. As one delves deeper into its chemistry and biological interactions, it can provide a gateway to understanding how subtle changes in chemical structure can lead to profound effects in biological systems.
Synonyms
urapidil
34661-75-1
Ebrantil
Eupressyl
Mediatensyl
Uraprene
6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil
B-66256
NSC 310405
6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethylpyrimidine-2,4-dione
NSC-310405
A78GF17HJS
6-(3-(4-(o-Methoxyphenyl)-1-piperazinyl)propylamino)-1,3-dimethyluracil
MLS003115907
DTXSID9021425
NCGC00016066-07
Ebrantil (TN)
6-((3-(4-(o-Methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyluracil
2,4(1H,3H)-Pyrimidinedione, 6-((3-(4-(2-methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-
Urapidilum
Urapidilum [INN-Latin]
6-[[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyluracil
6-[3-[4-(o-Methoxyphenyl)-1-piperazinyl]propylamino]-1,3-dimethyluracil
2,4(1H,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
6-((3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
EINECS 252-130-4
CAS-64887-14-5
UNII-A78GF17HJS
Urapidil [INN:BAN:JAN]
BRN 0725782
Urapidil,(S)
6-({3-[4-(2-methoxyphenyl)piperazin-1-yl]propyl}amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
MFCD00133908
Urapidil (Standard)
Spectrum_001360
Tocris-1772
SpecPlus_000683
Lopac-U-100
URAPIDIL [INN]
URAPIDIL [JAN]
URAPIDIL [MI]
Prestwick0_000905
Prestwick1_000905
Prestwick2_000905
Prestwick3_000905
Spectrum2_001172
Spectrum3_001557
Spectrum4_000233
Spectrum5_001611
Urapidil (JP17/INN)
URAPIDIL [MART.]
URAPIDIL [WHO-DD]
2,4(1H,3H)-dione
Lopac0_001265
SCHEMBL48992
BSPBio_000750
BSPBio_003034
KBioGR_000925
KBioSS_001840
5-25-15-00402 (Beilstein Handbook Reference)
DivK1c_006779
SPECTRUM1503100
SPBio_001183
SPBio_002949
BPBio1_000826
CHEMBL279229
DTXCID501425
CHEBI:32278
GTPL13357
HY-B0716R
KBio1_001723
KBio2_001840
KBio2_004408
KBio2_006976
KBio3_002534
BCPP000025
HMS1922E11
BCP02494
HY-B0716
Tox21_110298
BDBM50237617
CCG-40329
NSC310405
s5965
STL454353
propylamino)-1,3-dimethylpyrimidine-
AKOS015896920
AC-8246
DB12661
FU34927
KS-5208
SDCCGSBI-0051232.P004
URACIL, 1,3-DIMETHYL-6-(3-(4-(o-METHOXYPHENYL)-1-PIPERAZINYL)PROPPYLAMINO)-
NCGC00016066-01
NCGC00016066-02
NCGC00016066-03
NCGC00016066-04
NCGC00016066-05
NCGC00016066-06
NCGC00016066-08
NCGC00016066-09
NCGC00016066-10
NCGC00016066-11
NCGC00016066-16
NCGC00016066-22
NCGC00025290-01
NCGC00025290-02
NCGC00025290-03
NCGC00025290-04
NCGC00025290-05
NCGC00178336-01
NCGC00178336-02
1,3-dimethyl-6-[(3-{4-[2-(methyloxy)phenyl]piperazin-1-yl}propyl)amino]pyrimidine-2,4(1H,3H)-dione
6-((3-(4-(2-Methoxyphenyl)-1-piperazinyl)propyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
SMR001831470
BCP0726000257
SBI-0051232.P003
CAS-34661-75-1
AB00514699
CS-0009600
NS00009232
U0085
6-(3-(4-(2-methoxyphenyl)piperazin-1-yl)
B66256
D01333
F15008
AB00053328_10
AB00053328_11
B 66256
L005359
Q418922
BRD-K73196317-001-02-7
BRD-K73196317-003-03-1
BRD-K73196317-003-07-2
BRD-K73196317-003-13-0
BRD-K73196317-003-14-8
BRD-K73196317-003-15-5
6-[3-[4-(2-Methoxyphenyl)piperazinyl]propylamino]-1,3-dimethyluracil
Uracil,3-dimethyl-6-[3-[4-(o-methoxyphenyl)-1-piperazinyl]proppylamino]-
Uracil, 1,3-dimethyl-6-(3-(4-(o-methoxyphenyl)-1-piperazinyl)propylamino)-
2,3H)-Pyrimidinedione, 6-[[3-[4-(2-methoxyphenyl)-1-piperazinyl]propyl]amino]-1,3-dimethyl-
6-((3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione #
6-(3-(4-(2-methoxyphenyl)piperazin-1-yl)propylamino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione
Ebrantil, 6-[[3-[4-(2-Methoxyphenyl)-1-piperazinyl]propyl]- amino]-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione
Solubility of 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethyl-pyrimidine-2,4-dione
The solubility of the compound 6-[3-[4-(2-methoxyphenyl)piperazin-1-yl]propylamino]-1,3-dimethyl-pyrimidine-2,4-dione (C21H31N5O2) can be assessed based on its structural features and chemical properties. Generally, solubility in solvents may vary considerably due to:
As a result, its solubility profile is likely to show:
In conclusion, while the solubility behavior of C21H31N5O2 is hypothesized based on its functional groups, definitive solubility data must be obtained through experimental analysis to better understand its practical applications.